Weight-loss medications have become one of the most talked-about topics in healthcare — and now Medicare is entering the conversation in a new way. Starting July 1, 2026, CMS is launching the Medicare GLP-1 bridge, a short-term demonstration program designed to expand access to weight-management GLP-1 medications for eligible beneficiaries.
 
Join Ryan Kocher, Senior Vice President of Medicare Advantage, and Anna Patrick, Vice President of Sales Enablement and Technology Adoption, as they quickly break down what the GLP-1 bridge is, who may qualify, which medications are included, and what this means for agents serving Medicare clients. Together, they’ll discuss how this new program creates an opportunity for agents to lead more informed conversations around affordability, access, and the future of Medicare strategy.
 
If your clients are asking about GLP-1 drugs for weight loss, this is a timely training you won’t want to miss!